_:WkGSstby1228 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en_id>.
_:WkGSstby1228 <http://rdf.freebase.com/ns/type.value.value> "2878098".
_:WkGSstby1232 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/en>.
_:WkGSstby1232 <http://rdf.freebase.com/ns/type.value.value> "alemtuzumab".
_:WkGSstby1229 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:WkGSstby1229 <http://rdf.freebase.com/ns/type.value.value> "Alemtuzumab".
_:WkGSstby1234 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:WkGSstby1234 <http://rdf.freebase.com/ns/type.value.value> "CAMPATH-1H".
_:WkGSstby1231 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:WkGSstby1231 <http://rdf.freebase.com/ns/type.value.value> "Campath".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c992da> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.chronic_lymphocytic_leukemia>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c992da> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c992da> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c992da> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c992da> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.alemtuzumab>.
_:WkGSstby1230 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:WkGSstby1230 <http://rdf.freebase.com/ns/type.value.value> "Campath-1H".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e08f> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.b-cell_lymphoma>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e08f> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e08f> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e08f> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e08f> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.alemtuzumab>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.approval_date> "2001".
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1228.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1232.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1229.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1234.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1231.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1230.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.key> _:WkGSstby1233.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/medicine.drug.cas_number> "".
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/type.object.name> "Alemtuzumab"@en.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://creativecommons.org/ns#attributionName> "Source: Freebase - The World's database".
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/medicine.drug.atc_code> "L01XC04".
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.product.brand_name> "Campath"@en.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://creativecommons.org/ns#attributionURL> <http://www.freebase.com/view/en/alemtuzumab>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.product.developed_by> <http://rdf.freebase.com/ns/en.genzyme>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.product.developed_by> <http://rdf.freebase.com/ns/en.bayer>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c992da>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e08f>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7cb7f>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/common.topic.article> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000000844d38>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.topic>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/medicine.medical_treatment>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/medicine.drug>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.product>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.product.technology_involved> <http://rdf.freebase.com/ns/en.monoclonal_antibodies>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.product.technology_involved> <http://rdf.freebase.com/ns/en.humanized_monoclonal_antibody>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.biomolecule_or_target> <http://rdf.freebase.com/ns/en.cd52>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Alemtuzumab>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Campath-1H>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Campath>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/CAMPATH-1H>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/MabCampath>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://www.w3.org/1999/xhtml/vocab#license> <http://creativecommons.org/licenses/by/3.0/>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/base.bioventurist.product.stage_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/en.alemtuzumab> <http://rdf.freebase.com/ns/common.topic.image> <http://rdf.freebase.com/ns/wikipedia.images.commons_id.2167068>.
_:WkGSstby1233 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:WkGSstby1233 <http://rdf.freebase.com/ns/type.value.value> "MabCampath".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7cb7f> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.multiple_sclerosis>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7cb7f> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7cb7f> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7cb7f> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7cb7f> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.alemtuzumab>.